{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:02:55Z","timestamp":1789909375417,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","award":["91116004"],"award-info":[{"award-number":["91116004"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leiden University Medical Center","doi-asserted-by":"publisher","award":["171116"],"award-info":[{"award-number":["171116"]}],"id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["14760"],"award-info":[{"award-number":["14760"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jbc.2024.107645","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T13:24:20Z","timestamp":1723123460000},"page":"107645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epstein-Barr virus nuclear antigen EBNA3A modulates IRF3-dependent IFN\u03b2 expression"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0693-320X","authenticated-orcid":false,"given":"Sanne L.","family":"Landman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike E.","family":"Ressing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Gram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayman T.N.","family":"Tjokrodirijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"van Veelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Neefjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob C.","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9324-3404","authenticated-orcid":false,"given":"Annemarthe G.","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7917-1475","authenticated-orcid":false,"given":"Ilana","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107645_bib1","series-title":"Fields Virology","author":"Fields","year":"2007"},{"key":"10.1016\/j.jbc.2024.107645_bib2","series-title":"Epstein Barr Virus Volume 1; One Herpes Virus: Many Diseases","article-title":"The epigenetic life cycle of Epstein\u2013Barr virus","author":"Hammerschmidt","year":"2015"},{"key":"10.1016\/j.jbc.2024.107645_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib4","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jbc.2024.107645_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein\u2013Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2024.107645_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107645_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107645_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/pathogens10060763","article-title":"Investigation of long covid prevalence and its relationship to epstein-barr virus reactivation","volume":"10","author":"Gold","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.jbc.2024.107645_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molimm.2017.08.025","article-title":"Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure","volume":"91","author":"Gram","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbc.2024.107645_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cell.2009.06.015","article-title":"RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway","volume":"138","author":"Chiu","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107645_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ni.1779","article-title":"RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate","volume":"10","author":"Ablasser","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2024.107645_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41590-017-0005-y","article-title":"Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity","volume":"19","author":"Chiang","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2024.107645_bib13","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1038\/sj.emboj.7601314","article-title":"EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN","volume":"25","author":"Samanta","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.107645_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1099\/vir.0.005389-0","article-title":"Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible genelike receptors, which synergize to induce type I interferon production","volume":"90","author":"Rasmussen","year":"2009","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib15","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/cells12121650","article-title":"The role of RNA sensors in regulating innate immunity to Gammaherpesviral infections","volume":"12","author":"Zhang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2024.107645_bib16","doi-asserted-by":"crossref","first-page":"27278","DOI":"10.1074\/jbc.M111.256974","article-title":"Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-i (RIG-I)","volume":"286","author":"Binder","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107645_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107645_bib18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2024.107645_bib19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/v12070733","article-title":"Of keeping and tipping the balance: host regulation and viral modulation of IRF3-dependent IFNB1 expression","volume":"12","author":"Schwanke","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jbc.2024.107645_bib20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jbc.2024.107645_bib22","first-page":"E1034","article-title":"Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107645_bib23","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1128\/JVI.00235-07","article-title":"Inhibition of interferon regulatory factor 7 (IRF7)-Mediated interferon signal transduction by the Kaposi\u2019s sarcoma-associated herpesvirus viral IRF homolog vIRF3","volume":"81","author":"Joo","year":"2007","journal-title":"J\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib24","series-title":"Current Topics in Microbiology and Immunology","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-3-319-22834-1_12","article-title":"Immune evasion by Epstein-Barr virus","volume":"391","author":"Ressing","year":"2015"},{"key":"10.1016\/j.jbc.2024.107645_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/microorganisms7060183","article-title":"Epstein\u2013barr virus and innate immunity: friends or foes?","volume":"7","author":"Jangra","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.jbc.2024.107645_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1515\/BC.1999.029","article-title":"The Epstein-Barr virus nuclear antigen 2 (EBNA2), a protein required for B lymphocyte immortalization, induces the synthesis of type I interferon in Burkitt\u2019s lymphoma cell lines","volume":"380","author":"Kanda","year":"1999","journal-title":"Biol Chem"},{"key":"10.1016\/j.jbc.2024.107645_bib27","first-page":"4930","article-title":"The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt\u2019s lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3","volume":"12","author":"Kanda","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107645_bib28","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2018.01446","article-title":"Latent membrane protein 1 of Epstein-Barr virus promotes RIG-I degradation mediated by proteasome pathway","volume":"9","author":"Xu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2024.107645_bib29","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1038\/onc.2009.249","article-title":"The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation","volume":"28","author":"Shah","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2024.107645_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1159\/000479749","article-title":"Epstein-Barr virus miR-BART6-3p inhibits the RIG-I pathway","volume":"9","author":"Lu","year":"2017","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.jbc.2024.107645_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200246","article-title":"The oncogenic gamma herpesviruses Epstein-Barr virus (EBV) and Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) hijack retinoic acid-inducible gene I (RIG-I) facilitating both viral and tumour immune evasion","volume":"14","author":"Nash","year":"2022","journal-title":"Tumour Virus Res."},{"key":"10.1016\/j.jbc.2024.107645_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004656","article-title":"To be or not IIb: a multi-step process for epstein-barr virus latency establishment and consequences for B cell tumorigenesis","volume":"11","author":"Price","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2024.107645_bib33","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1128\/MCB.19.4.2465","article-title":"Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains","volume":"19","author":"Lin","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107645_bib34","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/jvi.63.6.2469-2475.1989","article-title":"The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels","volume":"63","author":"Hammerschmidt","year":"1989","journal-title":"J\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000506","article-title":"Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes","volume":"5","author":"Hertle","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2024.107645_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1096\/fj.05-4651fje","article-title":"Efficient nonviral gene delivery into primary lymphocytes from rats and mice","volume":"20","author":"Goffinet","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2024.107645_bib72","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1073\/pnas.0608491104","article-title":"Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1","volume":"104","author":"Peer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107645_bib37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1021\/acs.bioconjchem.0c00237","article-title":"Conditionally controlling human TLR2 activity via trans-cyclooctene caged ligands","volume":"31","author":"Van De Graaff","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jbc.2024.107645_bib38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cell.2011.03.023","article-title":"A\u00a0genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation","volume":"145","author":"Paul","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107645_bib39","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nbt.4201","article-title":"Efficient proximity labeling in living cells and organisms with TurboID","volume":"36","author":"Branon","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jbc.2024.107645_bib40","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1099\/vir.0.81927-0","article-title":"Epstein\u2013Barr virus nuclear antigen 3A contains six nuclear-localization signals","volume":"87","author":"Buck","year":"2006","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib41","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/jvi.70.5.3068-3074.1996","article-title":"The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa)","volume":"70","author":"Robertson","year":"1996","journal-title":"J\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib42","doi-asserted-by":"crossref","first-page":"47197","DOI":"10.1074\/jbc.M208116200","article-title":"Two nonconsensus sites in the epstein-barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminalbinding protein (CtBP)","volume":"277","author":"Hickabottom","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107645_bib43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00109-021-02107-w","article-title":"The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases","volume":"99","author":"Chen","year":"2021","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.jbc.2024.107645_bib44","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1128\/MCB.25.23.10379-10390.2005","article-title":"RBP-J\u03ba\/SHARP recruits CtIP\/CtBP corepressors to silence notch target genes","volume":"25","author":"Oswald","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107645_bib45","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1101\/gad.14.13.1553","article-title":"CBP\/p300 in cell growth, transformation, and development","volume":"14","author":"Goodman","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2024.107645_bib46","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/emboj\/17.4.1087","article-title":"Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP\/p300","volume":"17","author":"Yoneyama","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.107645_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1128\/JVI.75.1.90-99.2001","article-title":"Amino acids of epstein-barr virus nuclear antigen 3A essential for repression of J\u03ba-mediated transcription and their evolutionary conservation","volume":"75","author":"Dalbi\u00e8s-Tran","year":"2001","journal-title":"J\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib48","doi-asserted-by":"crossref","first-page":"10171","DOI":"10.1128\/JVI.79.16.10171-10179.2005","article-title":"Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-J\u03ba\/CBF1 is critical","volume":"79","author":"Maruo","year":"2005","journal-title":"J\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fcimb.2017.00195","article-title":"AGO2 negatively regulates type i interferon signaling pathway by competition binding IRF3 with CBP\/p300","volume":"7","author":"Wang","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.jbc.2024.107645_bib50","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.onc.1204163","article-title":"HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP\/p300 coactivators","volume":"20","author":"Lin","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2024.107645_bib51","series-title":"Herpes Virus: Many Diseases","article-title":"The EBNA3 family: two oncoproteins and a tumour suppressor that are central to the biology of EBV in B cells in: Epstein Barr Virus Volume 2; 1","author":"Allday","year":"2015"},{"key":"10.1016\/j.jbc.2024.107645_bib52","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1073\/pnas.1422580112","article-title":"Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes","volume":"112","author":"Schmidt","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107645_bib53","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1128\/JVI.03226-13","article-title":"An important role for mitochondrial antiviral signaling protein in the Kaposi\u2019s sarcoma-associated herpesvirus life cycle","volume":"88","author":"West","year":"2014","journal-title":"J\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib54","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2013.05.007","article-title":"Cytosolic sensing of viruses","volume":"38","author":"Goubau","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2024.107645_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007148","article-title":"cGAS and STING: at the intersection of DNA and RNA virus-sensing networks","volume":"14","author":"Ni","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2024.107645_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.804511","article-title":"Activation and evasion of RLR signaling by DNA virus infection","volume":"12","author":"Jia","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jbc.2024.107645_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2020.06.004","article-title":"Balancing STING in antimicrobial defense and autoinflammation","volume":"55","author":"Landman","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jbc.2024.107645_bib58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrmicro.2016.45","article-title":"Viral evasion of intracellular DNA and RNA sensing","volume":"14","author":"Chan","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2024.107645_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.955603","article-title":"Strategies of Epstein-Barr virus to evade innate antiviral immunity of its human host","volume":"13","author":"Albanese","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jbc.2024.107645_bib60","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.compbiomed.2009.08.006","article-title":"Comparative analysis of the Epstein-Barr virus encoded nuclear proteins of EBNA-3 family","volume":"39","author":"Yenamandra","year":"2009","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jbc.2024.107645_bib61","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.75.16.7749-7755.2001","article-title":"Physical and functional interactions between the Corepressor CtBP and the epstein-barr virus nuclear antigen EBNA3C","volume":"75","author":"Touitou","year":"2001","journal-title":"J\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib62","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1172\/JCI58092","article-title":"EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors","volume":"122","author":"White","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2024.107645_bib63","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1128\/MCB.20.15.5722-5735.2000","article-title":"Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha","volume":"20","author":"Murray","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107645_bib64","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/JVI.76.10.4699-4708.2002","article-title":"Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3\/HAT domains and cooperate in regulation of transcription and histone acetylation","volume":"76","author":"Subramanian","year":"2002","journal-title":"J\u00a0Virol."},{"key":"10.1016\/j.jbc.2024.107645_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003314","article-title":"The EBV latent antigen 3C inhibits apoptosis through targeted regulation of interferon regulatory factors 4 and 8","volume":"9","author":"Banerjee","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2024.107645_bib66","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3390\/v13122344","article-title":"Molecular basis of epstein\u2013barr virus latency establishment and lytic reactivation","volume":"13","author":"Murata","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jbc.2024.107645_bib67","doi-asserted-by":"crossref","first-page":"33358","DOI":"10.1074\/jbc.M110.138362","article-title":"Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency","volume":"285","author":"Iizasa","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107645_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000583","article-title":"Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy","volume":"2","author":"Adhikary","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.107645_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymthe.2003.11.021","article-title":"Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes","volume":"9","author":"Carlotti","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2024.107645_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129513","article-title":"Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines","volume":"1864","author":"Pirro","year":"2020","journal-title":"Biochim Biophys Acta Gen. Subj."},{"key":"10.1016\/j.jbc.2024.107645_bib71","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","article-title":"2016 update of the PRIDE database and its related tools","volume":"44","author":"Vizca\u00edno","year":"2016","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582402146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582402146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:38:28Z","timestamp":1734395908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582402146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S002192582402146X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107645","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus nuclear antigen EBNA3A modulates IRF3-dependent IFN\u03b2 expression","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107645"}}